# FDA Inspection 1136333 - RadMD - February 25, 2021

Source: https://www.keypedia.com/records/fda_inspections/radmd/60d337fe-a380-4c10-912d-56e675c5082b
Source feed: FDA_Inspections

> FDA Inspection 1136333 for RadMD on February 25, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1136333
- Company Name: RadMD
- Inspection Date: 2021-02-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1228619 - 2024-01-24](https://www.keypedia.com/records/fda_inspections/radmd/2581c44d-b978-47f3-aa4b-2b2fbdadf80a)
- [FDA Inspection 1215344 - 2023-08-04](https://www.keypedia.com/records/fda_inspections/radmd/aa743a9e-66da-4ef5-a2ab-10fa43a30150)

Company: https://www.keypedia.com/companies/radmd/71118c50-c84f-4c05-85fd-9db2dcb17806

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c